ATE368671T1 - Et-743 analoga als antitumoralverbindungen - Google Patents
Et-743 analoga als antitumoralverbindungenInfo
- Publication number
- ATE368671T1 ATE368671T1 AT04010399T AT04010399T ATE368671T1 AT E368671 T1 ATE368671 T1 AT E368671T1 AT 04010399 T AT04010399 T AT 04010399T AT 04010399 T AT04010399 T AT 04010399T AT E368671 T1 ATE368671 T1 AT E368671T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxy
- spiroamine
- analogas
- protecting group
- bridge
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Discharging, Photosensitive Material Shape In Electrophotography (AREA)
- Instruments For Viewing The Inside Of Hollow Bodies (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2000/001852 WO2000069862A2 (en) | 1999-05-14 | 2000-05-15 | Hemisynthetic method and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE368671T1 true ATE368671T1 (de) | 2007-08-15 |
Family
ID=34855248
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04010399T ATE368671T1 (de) | 2000-05-15 | 2001-05-15 | Et-743 analoga als antitumoralverbindungen |
| AT01929816T ATE300547T1 (de) | 2000-05-15 | 2001-05-15 | Synthetisches verfahren zur herstellung von ecteinascidin-derivaten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01929816T ATE300547T1 (de) | 2000-05-15 | 2001-05-15 | Synthetisches verfahren zur herstellung von ecteinascidin-derivaten |
Country Status (16)
| Country | Link |
|---|---|
| EP (3) | EP1287004B1 (de) |
| KR (2) | KR100830717B1 (de) |
| AT (2) | ATE368671T1 (de) |
| AU (2) | AU2001256496C1 (de) |
| DE (3) | DE60112286T2 (de) |
| DK (3) | DK1289999T3 (de) |
| EA (2) | EA006369B1 (de) |
| ES (2) | ES2248319T3 (de) |
| GB (1) | GB9918178D0 (de) |
| HU (1) | HU228789B1 (de) |
| MX (1) | MXPA02010701A (de) |
| NZ (2) | NZ532793A (de) |
| PL (1) | PL203745B1 (de) |
| PT (3) | PT1289999E (de) |
| SI (2) | SI1289999T1 (de) |
| UA (1) | UA75597C2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101188691B1 (ko) | 2004-10-29 | 2012-10-09 | 파르마 마르 에스.에이. | 엑티나시딘 및 디사카라이드를 포함하는 제제 |
| KR100676324B1 (ko) * | 2005-03-15 | 2007-01-30 | 삼성전자주식회사 | 디스플레이장치 |
| KR100676325B1 (ko) * | 2005-03-15 | 2007-01-30 | 삼성전자주식회사 | 디스플레이장치 |
| KR100712667B1 (ko) * | 2006-04-11 | 2007-05-02 | 재단법인서울대학교산학협력재단 | 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법 |
| WO2011147828A1 (en) | 2010-05-25 | 2011-12-01 | Pharma Mar, S.A. | Synthetic process for the manufacture of ecteinascidin compounds |
| LT3615544T (lt) | 2017-04-27 | 2023-05-10 | Pharma Mar S.A. | Priešnavikiniai junginiai |
| WO2020105068A1 (en) * | 2018-11-24 | 2020-05-28 | Natco Pharma Limited | Process for the preparation of ecteinascidin derivative and its intermediate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59225189A (ja) | 1983-06-03 | 1984-12-18 | Shionogi & Co Ltd | キノナミン誘導体およびその製造法 |
| EP0309477B1 (de) * | 1986-06-09 | 1991-11-06 | The Board Of Trustees Of The University Of Illinois | Ekteinascidine 729, 743, 745, 759a, 759b und 770 |
| US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
| US6124292A (en) * | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
-
1999
- 1999-08-02 GB GBGB9918178.6A patent/GB9918178D0/en not_active Ceased
-
2001
- 2001-05-15 PT PT01929813T patent/PT1289999E/pt unknown
- 2001-05-15 KR KR1020027015168A patent/KR100830717B1/ko not_active Expired - Fee Related
- 2001-05-15 DE DE60112286T patent/DE60112286T2/de not_active Expired - Lifetime
- 2001-05-15 ES ES01929816T patent/ES2248319T3/es not_active Expired - Lifetime
- 2001-05-15 EP EP01929816A patent/EP1287004B1/de not_active Expired - Lifetime
- 2001-05-15 EP EP01929813A patent/EP1289999B1/de not_active Expired - Lifetime
- 2001-05-15 PT PT01929816T patent/PT1287004E/pt unknown
- 2001-05-15 DE DE60129753T patent/DE60129753T2/de not_active Expired - Lifetime
- 2001-05-15 EP EP04010399A patent/EP1496060B1/de not_active Expired - Lifetime
- 2001-05-15 SI SI200130244T patent/SI1289999T1/xx unknown
- 2001-05-15 PT PT04010399T patent/PT1496060E/pt unknown
- 2001-05-15 AU AU2001256496A patent/AU2001256496C1/en not_active Expired
- 2001-05-15 HU HU0300648A patent/HU228789B1/hu unknown
- 2001-05-15 DK DK01929813T patent/DK1289999T3/da active
- 2001-05-15 EA EA200201210A patent/EA006369B1/ru not_active IP Right Cessation
- 2001-05-15 AT AT04010399T patent/ATE368671T1/de active
- 2001-05-15 DK DK04010399T patent/DK1496060T3/da active
- 2001-05-15 AU AU56493/01A patent/AU783563B2/en not_active Expired
- 2001-05-15 PL PL358143A patent/PL203745B1/pl unknown
- 2001-05-15 KR KR1020027014555A patent/KR100777464B1/ko not_active Expired - Lifetime
- 2001-05-15 UA UA20021210093A patent/UA75597C2/uk unknown
- 2001-05-15 NZ NZ532793A patent/NZ532793A/en not_active IP Right Cessation
- 2001-05-15 SI SI200130777T patent/SI1496060T1/sl unknown
- 2001-05-15 MX MXPA02010701A patent/MXPA02010701A/es active IP Right Grant
- 2001-05-15 DK DK01929816T patent/DK1287004T3/da active
- 2001-05-15 DE DE60107241T patent/DE60107241T2/de not_active Expired - Lifetime
- 2001-05-15 EA EA200201209A patent/EA006070B1/ru not_active IP Right Cessation
- 2001-05-15 AT AT01929816T patent/ATE300547T1/de active
- 2001-05-15 NZ NZ521807A patent/NZ521807A/en not_active IP Right Cessation
- 2001-05-15 ES ES04010399T patent/ES2290583T3/es not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL358258A1 (en) | Antitumoral analogs of et-743 | |
| LU91751I2 (fr) | Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®) | |
| BG103945A (bg) | Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а | |
| LU91206I2 (fr) | Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel) | |
| BR0111263A (pt) | Derivados de 2-aminocarbonil-9h-purina | |
| BR9815166A (pt) | "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral" | |
| ATE527247T1 (de) | Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| ES2141957T3 (es) | Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. | |
| ZM987A1 (en) | New dihydrobenzofuran and chroman-carboxamide derivatives,processes for the preparation thereof and use thereof as neuroleptics | |
| BR9507231A (pt) | Uso de derivados de ácido carboxílico para a produção de drogas | |
| DE60107241D1 (de) | Et-743 analoga als antitumoralverbindungen | |
| HUP0204354A2 (hu) | Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| IL75238A (en) | Bis-(4-aminophenyl)sulfones,their preparation and pharmaceutical compositions containing them | |
| FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
| SE0004462D0 (sv) | Novel method and use | |
| FI950209A0 (fi) | Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset | |
| NO982107D0 (no) | Fremstilling av et salt av klavulansyre | |
| FI954218A0 (fi) | Bentsopyraaneja kaliumkanavan avaajina | |
| ATE162401T1 (de) | Antivitale zusammensetzungen | |
| DE69411380D1 (de) | Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1496060 Country of ref document: EP |